Tokai Pharmaceuticals Inc. (Nasdaq: TKAI) announced that its Board of Directors has initiated a review of strategic alternatives for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE